Role of dorsal raphe nucleus serotonin 5-HT(1A) receptor in the regulation of REM sleep

Life Sciences

Volumn 66, Issue 21, 2000, Pages 1999-2012

  Monti, Jaime M ^a,c   Monti, Daniel ^b  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NONE   (Uruguay)

Author keywords

8 OHDPAT; Dorsal raphe nucleus; DRN firing rate; REM sleep; Somatodendritic 5 HT(1A) receptor; WAY 100635

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 [4 [4 (1,1,3 TRIOXO 2H 1,2 BENZISOTHIAZOL 2 YL)BUTYL] 1 PIPERAZINYL] 1H INDOLE 2 CARBOXYLIC ACID METHYL ESTER; 4 AMINOBUTYRIC ACID A RECEPTOR; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA ADRENERGIC RECEPTOR; BUSPIRONE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLESINOXAN; GEPIRONE; HISTAMINE H2 RECEPTOR; IPSAPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; PINDOLOL; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

CHOLINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; ELECTROPHYSIOLOGY; HUMAN; MICRODIALYSIS; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; REM SLEEP; RETICULAR FORMATION; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SHORT SURVEY; SLOW WAVE SLEEP;

ELECTROPHYSIOLOGY; HUMANS; MESENCEPHALON; NEURONS; RAPHE NUCLEI; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RETICULAR FORMATION; SLEEP, REM;

ANIMALIA;

EID: 0034646991     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00649-9     Document Type: Short Survey

References (89)

1. R.W. McCarley, and J.A. Hobson, Science 189 58-60 (1975).
2. J.A. Hobson, R. Stickgold and E.F. Pace-Schott, Neuroreport 9 R1-R14 (1998).
3. S. De Lacalle and C.B. Saper, Handbook of Chemical Neuroanatomy, F.E. Bloom, A Björklund and T. Hökfelt (Eds), Vol. 13, 217-261, Elsevier, Amsterdam (1997).
4. V. Nemcová, P. Petrovický and H.J. Ten Donkelaar, J. Brain Res. 38 231-241 (1997).
5. D.B. Rye, Sleep 20 757-788 (1997).
6. N.B. Reese, E. García-Rill and R.D. Skinner, Progr. Neurobiol. 42 105-133 (1995).
7. B. Ford, C.J. Holmes, L. Mainville and B. Jones, J. Comp. Neurol. 363 177-196 (1995).
8. S.C. Oakman, P.L. Faris, P.E. Kerr, C. Cozzari and B.K. Hartman, J. Neurosci. 15 5859-5869 (1995).
9. B.E. Jones, Neuroscience 40 637-656 (1991).
10. C. Peyron, J.-M. Petit, C. Rampon, M. Jouvet and P.-H. Luppi, Neuroscience 82 443-468 (1998).
11. J. Ochi and K. Shimizu, Neurosci. Lett. 8 317-320 (1978).
12. D. Van der Kooy, S.P. Hunt, H.W.M. Steinbusch and A.A.J. Verhofstad, Neurosci. Lett. 26 25-30 (1981).
13. R.P. Vertes, J. Comp. Neurol. 313 643-668 (1991).
14. K.G. Baker and G.M. Halliday, Neurotransmitters in Human Brain, D.J. Tracey, G. Paxinos and J. Stone (Eds.), 155-171, Plenum Press, New York (1994).
15. J.G. Hensler, R.C. Ferry, D.M. Labow, G.B. Kovachich and A. Frazer, Synapse 17 1-15 (1994).
16. R. McQuade and T. Sharp, J. Neurochem. 69 791-796 (1997).
17. R.P. Vertes and B. Kocsis, J. Comp. Neurol. 340 11-26 (1994).
18. T. Honda and K. Semba, Brain Res. 647 299-306 (1994).
19. T.L. Steininger, W.H. Wainer, R.D. Blakely and D.B. Rye, J. Comp. Neurol. 382 302-322 (1997).
20. M. Tohyama and K. Takatsuji, Atlas of Neuroactive Substances and Their Receptors in the Rat, 1-337, Oxford University Press, Oxford (1998).
21. K. Semba, J. Comp. Neurol. 330 543-556 (1993).
22. R.P. Vertes and A.M. Crane, J. Comp. Neurol. 378 411-424 (1997).
23. B.J. Losier and K. Semba, Brain Res. 604 41-52 (1993).
24. E.J. Van Bockstaele, A. Biswas and V.M. Pickel, Brain Res. 624 188-198 (1993).
25. A. Gonzalo-Ruiz, A.R. Lieberman and J.M. Sanz-Anquela, J. Chem. Neuroanat. 8 103-115 (1995).
26. H. Iwakiri, K. Matsuyama and S. Mori, Neurosci. Res. 18 157-170 (1993).
27. M.A. Bunin, C. Prioleau, R.B. Mailman and R.M. Wightman, J. Neurochem. 70 1077-1087 (1998).
28. M. Hajós, C.D. Richards, A.D. Székely and T. Sharp, Neuroscience 87 95-108 (1998).
29. K. Semba and H.C. Fibiger, J. Comp. Neurol. 323 387-410 (1992).
30. C.S. Leonard and R. Llinas, Neuroscience 59 309-330 (1994).
31. K. Takakusaki, T. Shiroyama and S.T. Kitai, Neuroscience 79 1089-1109 (1997).
32. R.W. McCarley, J.P. Nelson and J.A. Hobson, Science 201 209-262 (1978).
33. T. Kodama, Y. Takahiashi and Y. Honda, Neurosci. Lett. 114 277-282 (1990).
34. Y. Kayama, M. Ohta and E. Jodo, Brain Res. 569 210-220 (1992).
35. S.J. Shammah-Lagnado, N. Negrao, B.A. Silva and J.A. Ricardo, Neuroscience 20 961-989 (1987).
36. H. Iwakiri, K. Takekusaki, S. Nonaka and S. Mori, Neurosci. Lett. 177 19-22 (1994).
37. M.E. Trulson, and B.L. Jacobs, Brain Res. 163 135-150 (1979).
38. R.W. McCarley, R.W. Greene, D. Rainnie and C.M. Portas, Sem. Neurosci. 7 341-354 (1995).
39. C.M. Portas and R.W. McCarley, Brain Res. 648 306-312 (1994).
40. C.A. Fornal, F. Marrosu, C.W. Metzler, K. Tada and B.L. Jacobs, J. Pharmacol. Exptl Ther. 270 1359-1366 (1994).
41. Q.P. Wang, D.J. Laurie, P.H. Seeburg and A. Bach, Brain Res. Bull. 29 943-948 (1992).
42. J.A. Stamp and K. Semba, Brain Res. 677 39-49 (1995).
43. D. Nitz and J. Siegel, Soc. Neurosci. Abstr. 19 742 (1993).
44. D. Nitz and J. Siegel, Neuroscience 78 795-801 (1997).
45. M. Lancel, T.A.M. Crönlein and J. Faulhaber, Neuropsychopharmacology 15 63-74 (1996).
46. D. Nitz and J. Siegel, Am. J. Physiol. 273 R451-R455 (1997).
47. S.E. Levine and B.L. Jacobs, Neuroscience 12 4037-4044 (1992).
48. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mylecharane, P.R. Saxena and P.P.A. Humphrey, Pharmacol. Rev. 46 157-203 (1994).
49. D. Hoyer and G.R. Martin, Beh. Brain Res. 73 263-268 (1996).
50. M. Baez, J.D. Kursar, L.A. Helton, D.B. Wainscott and D.L.G. Nelson, Obesity Res. 3 (suppl. 4) 441S-447S (1995).
51. R.Y. Wang and G.K. Aghajanian, Brain Res. 132 186-193 (1977).
52. G.K. Aghajanian and J.M. Lakoski, Brain Res. 305 181-185 (1984).
53. J.S. Sprouse and G.K. Aghajanian, Synapse 1 3-9 (1987).
54. J.S. Sprouse and G.K. Aghajanian, Neuropharmacology 27 707-715 (1988).
55. A. Gobert, F. Lejeune, J.-M, Rivet, V. Audinot, A. Newman-Tancredi and M.J. Millan, J. Pharmacol. Exptl. Ther. 273 1032-1046 (1995).
56. V. Hillegaart, S. Hjorth and S. Ahlenius, J. Neural Transm. 81 131-145 (1990).
57. E.A. Forster, I.A. Cliffe, D.J. Bill, G.M. Dover, D. Jones, Y. Reilly and A. Fletcher, Eur. J. Pharmacol. 281 81-88 (1995).
58. A. Fletcher, E.A. Forster, D.J. Bill, G. Brown, I.A. Cliffe, J.E. Hartley, D.E. Jones, A. McLenachan, K.J. Stanhope, D.J.P. Critchley, K.J. Childs, V.C. Middlefell, L. Lanfumey, R. Corradetti, A.-M. Laporte, H. Gozlan, M. Hamon and C.T. Dourish, Behav. Brain Res. 73 337-353 (1996).
59. M.K. Mundey, A. Fletcher and C.A. Marsden, Br. J. Pharmac. 117 750-756 (1996).
60. C.A. Fornal, C.W. Metzler, R.A. Gallegos, S.C. Veasey, A.C. McReary and B.L. Jacobs, J. Pharmacol. Exptl. Ther. 278 752-762 (1996).
61. J.I. Luebke, R.W. Greene, K. Semba, A. Kamondi, R.W. McCarley and P.B. Reiner, Proc. Natl. Acad. Sci. USA 89 743-747 (1992).
62. M.C. Austin, J.A. Weikel, V. Arango and J.J. Mann, Synapse 18 276-279 (1994).
63. H.K. Kia, M.-C. Miquel, M.-J. Brisorgueil, G. Daval, M. Riad, S. El Mestikawy, M. Hamon and D. Vergé, J. Comp. Neurol. 365 289-305 (1996).
64. H.K. Kia, M.-J. Brisorgueil, M. Hamon, A. Calas and D. Vergé, J. Neurosci. Res. 46 697-708 (1996).
65. M.M. Thakkar, R.E. Strecker and R.W. McCarley, J. Neurosci. 18 5490-5497 (1998).
66. M.R. Dzoljic, P.R. Saxena and O.E. Ukponmwan, Sleep Res. 16 88 (1987).
67. 1A Receptors: Behavioral and Neurochemical Pharmacology, C.T. Dourish, S. Ahlenius and P.H. Huston (Eds), 135-139, Ellis Horwood, Chichester (1987).
68. C. Dugovic and A. Wauquier, Eur. J. Pharmacol. 137 145-146 (1987).
69. H. Depoortere, Sleep '86, W.P. Koella, F. Obál, H. Schulz and P. Visser (Eds), 346-348, Gustav Fischer Verlag, Sttutgart (1988).
70. J.M. Monti, C. Orellana, M. Boussard, H. Jantos, P. Labraga, S. Olivera and F. Alvariño, Biogen. Amines 7 145-151 (1990).
71. J. Van Proosdij and G. Ruigt, Sleep-Wake Research in The Netherlands, A.M.L. Coenen (Ed.), 121-127, Drukkerij Elinkwijk B.V., Utrecht (1994).
72. M. Kurosawa, K. Okada, A. Sato and S. Uchida, Neurosci. Lett. 161 73-76 (1993).
73. J.M. Monti and H. Jantos, J. Sleep Res. 1 169-175 (1992).
74. J.M. Monti, H. Jantos, R. Silveira, M. Reyes-Parada, C. Scorza and C. Prunell, Pyschopharmacology 115 273-277 (1994).
75. J.M. Monti, A. Ponzoni, H. Jantos and D. Monti, Sleep 22 (Suppl. 1) 218 (1999).
76. L.D. Sanford, R.J. Ross, A.E. Seggos, A.R. Morrison, W.A. Ball and G.L. Mann, Pharmacol. Biochem. Behav. 49 93-100 (1994).
77. R.L. Horner, L.D. Sanford, D. Annis, A.I. Pack and A.R. Morrison, J. Neurosci. 17 7541-7552 (1997).
78. C.M. Portas, M. Thakkar, D. Rainnie and R.W. McCarley, J. Neurosci. 16 2820-2828 (1996).
79. D.R. Stevens, R.W. McCarley and R.W. Greene, Neuroscience 47 545-553 (1992).
80. 1A Receptors in Depression and Anxiety, J.M. Gastpar, J.M. Keppel Hesselink and J. Traber (Eds), 35-53, Raven Press, New York (1992).
81. J.A. Lerman, K.I. Kaitin, W.C. Dement and S.J. Peroutka, Neurosci. Lett. 72 64-68 (1986).
82. J.M. Monti, H. Jantos, R. Silveira, M. Reyes-Parada and C. Scorza, Pharmacol. Biochem. Behav. 52 305-312 (1995).
83. W.F. Seidel, S.A. Cohen, N.G. Bliwise and W.C. Dement, Psychopharmacology 87 371-373 (1985).
84. R.L. Manfredi, A. Kales, A.N. Vgontzas, E.O. Bixler, M.A. Isaac and C.M. Falcone, Am. J. Psychiatry 148 1213-1217 (1991).
85. J.C. Gillin, W. Jernajczyk, D.C. Valladares-Neto, S. Golshan, M. Lardon and S.M. Stahl, Psychopharmacology 116 186-192 (1994).
86. H.S. Driver, M.J. Flanigan, A.J. Bentley, H.G. Luus, C.M. Shapiro and D. Mitchell, Psychopharmacology 117 186-192 (1995).
87. C. Routledge, J. Gurling, I.K. Wright and C.T. Dourish, Eur. J. Pharmacol. 239 195-202 (1993).
88. J.M. Monti and H. Jantos, Neuropharmacology 33 705-708 (1994).
89. E. Seifritz, S.M. Stahl and J.C. Gillin, Brain Res. 759 84-91 (1997).